Related Experiment Video
Updated: May 16, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
HCV NS5A inhibitors in development
1Division of Gastroenterology and Hepatology, University of Michigan Health System, University of Michigan, Ann Arbor, 48109, USA. aslok@umich.edu
Clinics in Liver Disease
|November 27, 2012
Summary
Daclatasvir effectively inhibits hepatitis C virus (HCV) replication. Combination therapies including daclatasvir show high response rates in patients with genotype 1 HCV infection.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) NS5A protein is crucial for viral replication.
- Daclatasvir (DCV) is a novel inhibitor targeting the HCV NS5A replication complex.
- DCV exhibits potent antiviral activity but has a limited barrier to resistance.
Purpose of the Study:
- To evaluate the efficacy of daclatasvir in combination therapies for hepatitis C virus infection.
- To assess treatment outcomes in different patient populations, including treatment-naïve and treatment-experienced individuals.
Main Methods:
- Clinical trials were conducted to assess triple and quadruple therapy regimens.
- Regimens included daclatasvir, pegylated interferon, ribavirin, and asunaprevir (NS3 protease inhibitor).
- Patient outcomes were measured by early virologic response and sustained virologic response rates.
Main Results:
- Triple therapy (DCV + pegylated interferon + ribavirin) achieved high early virologic response in treatment-naïve genotype 1 HCV patients.
- Quadruple therapy (DCV + asunaprevir + pegylated interferon + ribavirin) demonstrated high sustained virologic response in genotype 1 prior null responders.
- Daclatasvir-based regimens showed significant antiviral efficacy across different treatment scenarios.
Conclusions:
- Daclatasvir-based therapies are effective for treating hepatitis C virus genotype 1 infection.
- Combination therapy with daclatasvir offers promising outcomes for both treatment-naïve and difficult-to-treat patient groups.
- Further research may explore optimizing daclatasvir regimens for HCV eradication.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...